Track Deepcyte
— get Health deals in free daily digest
Overview
Deepcyte, a techbio company specializing in AI-driven toxicology for drug development, has launched with $1.5 million in seed funding. This funding will help advance its single-cell analysis platform and predictive AI tools, addressing challenges in drug development.
Products
Loading...
Recent Deals
Deepcyte, a techbio company specializing in AI-driven toxicology for drug development, has launched with $1.5 million in seed funding. This funding will help advance its single-cell analysis platform and predictive AI tools, addressing challenges in drug development.